Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Osteogenesis Imperfecta Type 3
Welcome,
Profile
Billing
Logout
1 Company
2 Products
2 Products
0 Mechanisms of Action
0 Trials
4 News
||||
||||||
zoledronic acid
/
Generic mfg.
Trial completion:
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
(clinicaltrials.gov) - May 31, 2017
P2
, N=127, Completed,
Sponsor: Novartis Pharmaceuticals
No longer recruiting --> Completed
||
||||||||
zoledronic acid
/
Generic mfg.
Trial completion, Enrollment change:
INFOI: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
(clinicaltrials.gov) - Apr 20, 2016
P3
, N=14, Completed,
Sponsor: Shriners Hospitals for Children
No longer recruiting --> Completed Active, not recruiting --> Completed | N=20 --> 14
|
|||||||||
zoledronic acid
/
Generic mfg.
Trial primary completion date:
INFOI: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
(clinicaltrials.gov) - Dec 31, 2015
P3
, N=20, Active, not recruiting,
Sponsor: Shriners Hospitals for Children
Active, not recruiting --> Completed | N=20 --> 14 Trial primary completion date: May 2015 --> Sep 2015
|
|||||||||
zoledronic acid
/
Generic mfg.
Enrollment closed:
INFOI: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
(clinicaltrials.gov) - Jun 3, 2013
P3
, N=20, Active, not recruiting,
Sponsor: Shriners Hospitals for Children
Trial primary completion date: May 2015 --> Sep 2015 Recruiting --> Active, not recruiting